(Q37340554)

19 August 2017

1 reference

title

Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents (English)

1 reference

19 August 2017

Thomas Kruse

1

1 reference

19 August 2017

Hans-Henrik Kristensen

series ordinal

2

1 reference

19 August 2017

publication date

1 December 2008

1 reference

Expert Review of Anti-infective Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

6

1 reference

19 August 2017

issue

6

1 reference

19 August 2017

page(s)

887-895

1 reference

Intracellular pattern recognition receptors in the host response

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Recognition of microorganisms and activation of the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Crystallization of antimicrobial pores in membranes: magainin and protegrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

The antibacterial peptide pyrrhocoricin inhibits the ATPase actions of DnaK and prevents chaperone-assisted protein folding

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Construction and characterization of mutations at codon 751 of the Escherichia coli gyrB gene that confer resistance to the antimicrobial peptide microcin B17 and alter the activity of DNA gyrase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

The co-evolution of host cationic antimicrobial peptides and microbial resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Reduced Paneth cell alpha-defensins in ileal Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Trends in development and approval times for new therapeutics in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Protein therapeutics: a summary and pharmacological classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Bioequivalence and the immunogenicity of biopharmaceuticals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Antimicrobial peptides: therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Defensins. Natural peptide antibiotics of human neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Defensin-6 mRNA in human Paneth cells: implications for antimicrobial peptides in host defense of the human bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

hBD-1: a novel beta-defensin from human plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

A peptide antibiotic from human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Defensins of vertebrate animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

A human homologue of the Drosophila Toll protein signals activation of adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Toll-like receptor signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

21 January 2018

The NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Production of beta-defensins by human airway epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Regulation of mammalian defensin expression by Toll-like receptor-dependent and independent signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Pathogen recognition with Toll-like receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Up-regulation of human beta-defensin 2 by interleukin-1beta in A549 cells: involvement of PI3K, PKC, p38 MAPK, JNK, and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Nod-like proteins in immunity, inflammation and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal alpha-defensin expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

The concentration-dependent chemokine release and pro-apoptotic effects of neutrophil-derived alpha-defensin-1 on human bronchial and alveolar epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Identification of defensin-1, defensin-2, and CAP37/azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Evaluation of the effects of peptide antibiotics human beta-defensins-1/-2 and LL-37 on histamine release and prostaglandin D(2) production from mast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Antimicrobial peptides human β-defensin (hBD)-3 and hBD-4 activate mast cells and increase skin vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Role of human neutrophil peptides in lung inflammation associated with α1-antitrypsin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Release of anti-HIV mediators after administration of leukotriene B4 to humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Resolvin E1 and protectin D1 activate inflammation-resolution programmes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Murine beta-defensin 2 promotes TLR-4/MyD88-mediated and NF-kappaB-dependent atypical death of APCs via activation of TNFR2

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Mechanisms for induction of acquired host immunity by neutrophil peptide defensins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Defensin-induced adaptive immunity in mice and its potential in preventing periodontal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

A -defensin mutation causes black coat color in domestic dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Can innate immunity be enhanced to treat microbial infections?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

A comprehensive map of the toll-like receptor signaling network

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Complexities of targeting innate immunity to treat infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

An anti-infective peptide that selectively modulates the innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Therapeutic potential of Toll-like receptor 9 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Translating innate immunity into immunological memory: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Drugs for bad bugs: confronting the challenges of antibacterial discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

Toll-dependent selection of microbial antigens for presentation by dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.6.887

21 January 2018

Identifiers

DOI

10.1586/14787210.6.6.887

1 reference

19 August 2017

1 reference